BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32003476)

  • 1. Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma.
    Dias AR; Pereira MA; Oliveira RJ; Ramos MFKP; Szor DJ; Ribeiro U; Zilberstein B; Cecconello I
    J Surg Oncol; 2020 Apr; 121(5):840-847. PubMed ID: 32003476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative.
    Tran TB; Worhunsky DJ; Norton JA; Squires MH; Jin LX; Spolverato G; Votanopoulos KI; Schmidt C; Weber S; Bloomston M; Cho CS; Levine EA; Fields RC; Pawlik TM; Maithel SK; Poultsides GA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S840-7. PubMed ID: 26148757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivisceral resection compared to standard gastrectomy for gastric adenocarcinoma: A propensity score-matching analysis.
    Dias AR; Pereira MA; Ramos MFKP; Ribeiro U; Zilberstein B; Nahas SC
    J Surg Oncol; 2022 Jul; 126(1):99-107. PubMed ID: 35689584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction scores for complication and recurrence after multivisceral resection in gastric cancer.
    Dias AR; Pereira MA; Ramos MFKP; Oliveira RJ; Ribeiro U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2020 Jun; 46(6):1097-1102. PubMed ID: 31987704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
    Roukos D; Schmidt-Mathiesen A; Encke A
    Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative.
    Jin LX; Sanford DE; Squires MH; Moses LE; Yan Y; Poultsides GA; Votanopoulos KI; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine EA; Winslow E; Saunders N; Spolverato G; Colditz GA; Maithel SK; Fields RC
    Ann Surg Oncol; 2016 Aug; 23(8):2398-408. PubMed ID: 27006126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control study.
    Charruf AZ; Ramos MFKP; Pereira MA; Dias AR; de Castria TB; Zilberstein B; Cecconelo I; Ribeiro U
    J Surg Oncol; 2020 Apr; 121(5):833-839. PubMed ID: 31943232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?
    Martin RC; Jaques DP; Brennan MF; Karpeh M
    J Am Coll Surg; 2002 May; 194(5):568-77. PubMed ID: 12025834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
    Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
    J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors Affecting Survival After Multivisceral Resection in Patients with Clinical T4b Gastric Cancer.
    Mita K; Ito H; Katsube T; Tsuboi A; Yamazaki N; Asakawa H; Hayashi T; Fujino K
    J Gastrointest Surg; 2017 Dec; 21(12):1993-1999. PubMed ID: 28940122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivisceral Resection for Locally Advanced Gastric Cancer.
    Aversa JG; Diggs LP; Hagerty BL; Dominguez DA; Ituarte PHG; Hernandez JM; Davis JL; Blakely AM
    J Gastrointest Surg; 2021 Mar; 25(3):609-622. PubMed ID: 32705611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Gastric Cancer Resection in Octogenarians: A Multi-institutional Study of the U.S. Gastric Cancer Collaborative.
    Tran TB; Worhunsky DJ; Squires MH; Jin LX; Spolverato G; Votanopoulos KI; Schmidt C; Weber S; Bloomston M; Cho CS; Levine EA; Fields RC; Pawlik TM; Maithel SK; Norton JA; Poultsides GA
    Ann Surg Oncol; 2015 Dec; 22(13):4371-9. PubMed ID: 25822782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.
    Pacelli F; Cusumano G; Rosa F; Marrelli D; Dicosmo M; Cipollari C; Marchet A; Scaringi S; Rausei S; di Leo A; Roviello F; de Manzoni G; Nitti D; Tonelli F; Doglietto GB;
    JAMA Surg; 2013 Apr; 148(4):353-60. PubMed ID: 23715879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
    Vicente D; Ikoma N; Chiang YJ; Fournier K; Tzeng CD; Song S; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2018 Sep; 25(9):2720-2730. PubMed ID: 29987602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.
    Claassen YHM; Hartgrink HH; Dikken JL; de Steur WO; van Sandick JW; van Grieken NCT; Cats A; Trip AK; Jansen EPM; Meershoek-Klein Kranenbarg WM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
    Eur J Surg Oncol; 2018 May; 44(5):613-619. PubMed ID: 29503129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.
    Singh B; Fisher OM; Singh G; Lansom J; Bock M; Kozman M; Alzahrani N; Liauw W; Morris DL
    Ann Surg Oncol; 2019 Oct; 26(11):3627-3635. PubMed ID: 31292804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study.
    Kelly KJ; Selby L; Chou JF; Dukleska K; Capanu M; Coit DG; Brennan MF; Strong VE
    Ann Surg Oncol; 2015 Oct; 22(11):3590-6. PubMed ID: 25631063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.
    Fuentes E; Ahmad R; Hong TS; Clark JW; Kwak EL; Rattner DW; Mullen JT
    J Surg Oncol; 2016 Apr; 113(5):560-4. PubMed ID: 26792144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended multiorgan resection in locally advanced gastric cancer: a single centre experience from south India.
    Deshpande G; Samarasam I; Chandran BS; Abraham V; George SV; Mathew G
    Trop Gastroenterol; 2013; 34(4):259-63. PubMed ID: 25046889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.